| pubmed-article:9123736 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9123736 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:9123736 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9123736 | lifeskim:mentions | umls-concept:C0002844 | lld:lifeskim |
| pubmed-article:9123736 | lifeskim:mentions | umls-concept:C0392360 | lld:lifeskim |
| pubmed-article:9123736 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:9123736 | lifeskim:mentions | umls-concept:C0871712 | lld:lifeskim |
| pubmed-article:9123736 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
| pubmed-article:9123736 | lifeskim:mentions | umls-concept:C2699007 | lld:lifeskim |
| pubmed-article:9123736 | lifeskim:mentions | umls-concept:C1513120 | lld:lifeskim |
| pubmed-article:9123736 | pubmed:issue | 3A Suppl | lld:pubmed |
| pubmed-article:9123736 | pubmed:dateCreated | 1997-4-24 | lld:pubmed |
| pubmed-article:9123736 | pubmed:abstractText | The use of neoadjuvant chemotherapy prior to definitive surgery has been firmly established in other areas of oncology, most notably in the treatment to testis and Wilm's tumors. The use of neoadjuvant androgen deprivation therapy (ADT) in conjunction with radical prostatectomy remains a source of controversy. We have conducted phase II and phase III studies to assess the effects of 3 months of preoperative ADT (goserelin and flutamide) on the pathologic staging and postsurgery prostate-specific antigen (PSA) relapse rate. We also reviewed the data confirming the understaging of clinically localized prostatic cancer and the experimental data providing the conceptual support for ADT. | lld:pubmed |
| pubmed-article:9123736 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9123736 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9123736 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9123736 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9123736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9123736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9123736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9123736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9123736 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9123736 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:9123736 | pubmed:issn | 0090-4295 | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:SheinfeldJJ | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:HertJJ | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:FairW RWR | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:HestonW DWD | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:CohenDD | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:WangYY | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:BeggC BCB | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:RussoPP | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:SoganiPP | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:ReuterV EVE | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:StroumbakisNN | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:CooksonM SMS | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:AprikianA GAG | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:SolowayS MSM | lld:pubmed |
| pubmed-article:9123736 | pubmed:author | pubmed-author:DalgabniGG | lld:pubmed |
| pubmed-article:9123736 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9123736 | pubmed:volume | 49 | lld:pubmed |
| pubmed-article:9123736 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9123736 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9123736 | pubmed:pagination | 46-55 | lld:pubmed |
| pubmed-article:9123736 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:9123736 | pubmed:meshHeading | pubmed-meshheading:9123736-... | lld:pubmed |
| pubmed-article:9123736 | pubmed:meshHeading | pubmed-meshheading:9123736-... | lld:pubmed |
| pubmed-article:9123736 | pubmed:meshHeading | pubmed-meshheading:9123736-... | lld:pubmed |
| pubmed-article:9123736 | pubmed:meshHeading | pubmed-meshheading:9123736-... | lld:pubmed |
| pubmed-article:9123736 | pubmed:meshHeading | pubmed-meshheading:9123736-... | lld:pubmed |
| pubmed-article:9123736 | pubmed:meshHeading | pubmed-meshheading:9123736-... | lld:pubmed |
| pubmed-article:9123736 | pubmed:meshHeading | pubmed-meshheading:9123736-... | lld:pubmed |
| pubmed-article:9123736 | pubmed:meshHeading | pubmed-meshheading:9123736-... | lld:pubmed |
| pubmed-article:9123736 | pubmed:meshHeading | pubmed-meshheading:9123736-... | lld:pubmed |
| pubmed-article:9123736 | pubmed:meshHeading | pubmed-meshheading:9123736-... | lld:pubmed |
| pubmed-article:9123736 | pubmed:meshHeading | pubmed-meshheading:9123736-... | lld:pubmed |
| pubmed-article:9123736 | pubmed:meshHeading | pubmed-meshheading:9123736-... | lld:pubmed |
| pubmed-article:9123736 | pubmed:meshHeading | pubmed-meshheading:9123736-... | lld:pubmed |
| pubmed-article:9123736 | pubmed:meshHeading | pubmed-meshheading:9123736-... | lld:pubmed |
| pubmed-article:9123736 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9123736 | pubmed:articleTitle | The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results. | lld:pubmed |
| pubmed-article:9123736 | pubmed:affiliation | Department of Surgery, Pathology, and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. | lld:pubmed |
| pubmed-article:9123736 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9123736 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9123736 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9123736 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9123736 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| pubmed-article:9123736 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9123736 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9123736 | lld:pubmed |
